R & D- medical: biomedical (basic research)

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN268201200003I
Awardee
Awarding agency
Task orders
7 $9,052,917 obligated

Award facts

Opportunity
Combined order value
$9,052,917 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 91% used
$9,958,057.00
Maximum order
$9,333,057.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
2 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart, Lung, and Blood Institute (NHLBI), a civilian component of the National Institutes of Health (NIH), awarded a single-award Indefinite Delivery Contract valued at $9.96 million to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for the Gene Therapy Resource Program (GTRP) Pharmacology-Toxicology Core Lab. The contract, awarded on April 16, 2012, with an ultimate completion date of April 15, 2017, provides preclinical research and development services focused on biomedical and basic research in support of respiratory disease treatment and cure development. LBERI, a not-for-profit contract research organization doing business as Inhalation Toxicology Research Institute and operating as a subsidiary of Lovelace Biomedical Research Institute, leverages over 70 years of specialized expertise in inhalation toxicology, infectious disease modeling, and medical countermeasure testing. All work is performed at the contractor's facility in Albuquerque, New Mexico, with no small business set-aside designation applied.

The contract generated multiple delivery orders through fiscal years 2012 through 2016, utilizing both cost-plus-fixed-fee and cost-no-fee pricing structures. Task orders ranged from approximately $252,588 to $4.56 million in ceiling values and addressed specific laboratory service areas including pharmacology-toxicology core laboratory services, gene therapy resource support, and specialized project work such as the BRIDGS Evans Project. The cumulative delivery orders demonstrate sustained funding for core laboratory operations and specialized task areas supporting the GTRP's mission to facilitate gene therapy research and development. As the prime contractor, LBERI provided comprehensive preclinical research capabilities essential to advancing therapeutic development for respiratory and other disease conditions under federal agency sponsorship.

Task orders

Transactions

Action Obligated Date
Change Order 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 1 $0
Other Administrative Action 2 $0
Original award $0

Quick answers

Who was awarded contract HHSN268201200003I?

HHSN268201200003I was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on April 16, 2012.

How much is contract HHSN268201200003I worth?

Orders under HHSN268201200003I have obligated $9,052,917. HHSN268201200003I's own ceiling is $9,958,057. A single order can be worth up to $9,333,057.

How many orders have been placed under contract HHSN268201200003I?

7 orders have been placed under HHSN268201200003I, the latest on January 29, 2016.

Who can order from contract HHSN268201200003I?

HHSN268201200003I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN268201200003I competed?

The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV